Ichor Therapeutics Rebrands as Ichor Life Sciences, Focuses on Contract Research Work and Strategic Programs

September 9, 2021 9:00 AM

LAFAYETTE, NY / ACCESSWIRE / September 9, 2021 / Ichor Therapeutics is now known as Ichor Life Sciences. The new name reflects Ichor Life Sciences' emphasis on delivering premium preclinical contract research and custom programs in discovery through pharmacology from its R&D facilities in LaFayette and Potsdam, both located in the Finger Lakes intellectual corridor of upstate New York.Ichor Life Sciences services customers in numerous...

Read more

Xenetic Biosciences, Inc. Receives Notice of Allowance for XCART(TM) Patent

September 9, 2021 8:05 AM

Allowance bolsters intellectual property portfolio for differentiated personalized CAR T platform technology, XCARTFRAMINGHAM, MA / ACCESSWIRE / September 9, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, today announced the United States Patent and...

Read more

Pieris Pharmaceuticals to Participate in Upcoming Investor Conferences

September 9, 2021 8:00 AM

BOSTON, MA / ACCESSWIRE / September 9, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, today announced that members of the management team will participate in the following upcoming investor conferences:H.C. Wainwright 23rd Annual Global Investment...

Read more

Lexaria to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 9, 2021 7:05 AM

KELOWNA, BC / ACCESSWIRE / September 9, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces today that Chairman & CEO Chris Bunka will present at the 23rd Annual H.C. Wainwright Global Investment Conference which is being held virtually from September 13-15, 2021.Mr. Bunka will provide an overview of the Company's latest news and updates which will...

Read more

Edesa Biotech to Present at the H.C. Wainwright Global Investment Conference

September 9, 2021 7:00 AM

TORONTO, ON / ACCESSWIRE / September 9, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that Dr. Par Nijhawan, Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually from September 13 to 15, 2021. Dr. Nijhawan is expected to provide an overview of Edesa's business and...

Read more

BioLargo to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021

September 8, 2021 8:30 AM

WESTMINSTER, CA / ACCESSWIRE / September 8, 2021 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, will present at the H.C. Wainwright 23rd Annual Global Investment Conference. The conference is being held virtually on September 13-15, 2021.President and CEO of BioLargo Dennis Calvert will present on the company's cleantech products and services, such as its newly launched...

Read more

Applied UV Continues Global Expansion with Airocide(R) Installations in Vietnam

September 8, 2021 8:30 AM

Son Tay Hospital and the National Institute of Food Control to install Airocide® technology to protect patients, visitors and staffMOUNT VERNON, NY / ACCESSWIRE / September 8, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy...

Read more

Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 8, 2021 8:00 AM

FRAMINGHAM, MA / ACCESSWIRE / September 8, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, today announced that Jeffrey F. Eisenberg, Chief Executive Officer of Xenetic will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference...

Read more

Viewpoint Molecular Targeting(R) to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 8, 2021 8:00 AM

CORALVILLE, IA / ACCESSWIRE / September 8, 2021 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing precision lead-212-based α-particle oncology therapeutics and complementary diagnostic imaging agents, today announced that Frances L. Johnson MD, Chief Executive Officer and Co-Founder of Viewpoint, will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference...

Read more

Lexaria Begins Investigational New Drug (IND) Enabling Program for DehydraTECH-CBD for Hypertension

September 8, 2021 7:05 AM

Positive results using DehydraTECH-CBD support progressing to FDA IND applicationKELOWNA, BC / ACCESSWIRE / September 8, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms today announced it is formally beginning the process towards an Investigational New Drug ("IND") application filing with the Food and Drug Administration ("FDA") with its...

Read more

Nanalysis Scientific Corp. to Present at the 10th Annual Gateway Conference on September 9, 2021

September 7, 2021 3:55 PM

CALGARY, AB / ACCESSWIRE / September 7, 2021 / Nanalysis Scientific Corp. (TSXV:NSCI)(OTCQX:NSCIF) has been invited to present at the 10th Annual Gateway Conference, which is being held virtually on September 8-9, 2021.Nanalysis CEO, Mr. Sean Krakiwsky, is scheduled to present on Thursday, September ­­9 at 11 a.m. Mountain time, with one-on-one meetings to be held throughout the conference. The presentation will be webcast live and...

Read more

Hancock Jaffe Laboratories Announces $20 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules

September 7, 2021 8:05 AM

IRVINE, CA / ACCESSWIRE / September 7, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has entered into a definitive agreement with a fund managed by Perceptive Advisors, a leading life sciences investment firm, to purchase $20 million of its common stock and pre-funded warrants in a registered direct offering priced at-the-market under Nasdaq...

Read more

Lexaria's Human Clinical Study Delivers Effective and Safe Blood Pressure Reduction Results over 24-hour Ambulatory Period

September 7, 2021 7:05 AM

Human Clinical Study HYPER-H21-2 evidences up to a remarkable 23% decrease in blood pressure with patented DehydraTECH-CBD relative to placeboKELOWNA, BC / ACCESSWIRE / September 7, 2021 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is extremely pleased to issue initial results from human clinical study HYPER-H21-2 evaluating DehydraTECHTM-processed cannabidiol...

Read more

BioLargo Launches PFAS Testing and Treatment System Selection Program

September 2, 2021 8:30 AM

WESTMINSTER, CA / ACCESSWIRE / September 2, 2021 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced that it has launched a new service offering to test customer water to determine PFAS contamination levels and advise on appropriate treatment equipment options to meet federal, state and local regulatory requirements. The program offers peace of mind and...

Read more

M2Bio Sciences Appoints Dr. Riyad Domingo as Chief Innovation Officer

September 2, 2021 8:30 AM

CAPE TOWN, SA / ACCESSWIRE / September 2, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following remarkable update:M2Bio SciencesTM is delighted to announce the appointment ofDr. Riyad Domingo as Chief Innovation Officer effective immediately.Dr. Domingo holds a PhD in Medical Biochemistry...

Read more

Hemogenyx Pharmaceuticals PLC Announces U.S. Approval of Monoclonal Antibody Patent

September 2, 2021 2:00 AM

LONDON, UK / ACCESSWIRE / September 2, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce that a further patent application entitled MONOCLONAL ANTIBODIES TO HUMAN FLT3/FLK2 RECEPTOR PROTEIN has been approved and issued by the United States Patent and Trademark Office. The patent was issued on 31 August 2021 as Patent Number US...

Read more

Dermata Therapeutics, Inc. Announces Appointment of Kyri Van Hoose as Senior Vice President, Chief Financial Officer

September 1, 2021 6:00 AM

SAN DIEGO, CA / ACCESSWIRE / September 1, 2021 / Dermata Therapeutics, Inc. ("Dermata," or the "Company") (NASDAQ:DRMA)(NASDAQ:DRMAW), a clinical-stage biopharmaceutical company focused on the development of novel dermatology therapies, today announced the appointment of Kyri Van Hoose as Senior Vice President, Chief Financial Officer. Ms. Van Hoose is a strategic and operational finance leader with over 20 years of experience, including more...

Read more

Thermic Science Completes Prototype Designs and Component Specifications for its Retail Thermic Infrared Portable Heaters, Moves Forward North American Manufacturing Contracts, Hi-Tech WIFI App, Remote Control Thermostat, for the North American Retail Consumer

August 31, 2021 8:35 AM

NASHVILLE, TN / ACCESSWIRE / August 31, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN:A1W61J)(ISIN:US29271J1097, (OTC:ENDO), is pleased to announce the company has successfully completed its prototype designs and component specifications for the Thermic Science Infrared Portable Heater product line and completing its first North American Manufacturing Contracts in the...

Read more

Ensysce Biosciences Sets September 2021 Conference Schedule

August 31, 2021 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / August 31, 2021 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug abuse and overdose, is scheduled to participate at the following industry and financial conferences during September 2021:10th Annual Gateway ConferenceDate and Time: Held virtually...

Read more

Gemina Labs Announces Research and Development Appointments

August 30, 2021 12:40 PM

VANCOUVER, BC / ACCESSWIRE / August 30, 2021 / Gemina Laboratories Ltd. (CSE:GLAB) (the "Company" or "Gemina") is pleased to announce several key hires within our Research and Development team.Research and Development AppointmentsWithin the Research and Development group, the Company has expanded its development competencies with the appointment of Elliot Hong as Vice President of Product Development. Mr. Hong is a mechanical engineer with over...

Read more